ATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled, phase 3 study of rucaparib plus nivolumab following front-line platinum-based chemotherapy in ovarian cancer
- Publication date
- 1 November 2018
- Publisher
- 'Royal College of Obstetricians & Gynaecologists (RCOG)'